心系全球新冠疫苗研发进展--Pharma Sources Insight第二期主要内容抢先看
点击上方蓝字
关注并星标我们
新冠疫苗何时上市牵动着全球人民的心。本期《Pharma Sources Insight》将介绍中美疫苗研发路径的差异，mRNA疫苗的研发历程以及全球在推动疫苗上市过程中面临的挑战。与此同时，通过阅读本期电子汇编，读者将了解到吸入制剂在中国市场的布局、乳腺癌化疗用药卡培他滨在中国的上市历程回顾、国内知名药企的仿制药盘点，以及CRO外包公司的优势和未来市场潜力。
作为服务制药行业多年的高端互联网贸易平台，PharmaSources.com致力于为CPhI & P-MEC China展商及有需求的国内药企建立打开国际市场的贸易、对话渠道，而《Pharma Sources Insight》的诞生让世界制药人士又多了一个了解中国市场及药企动态的窗口。
本期《Pharma Sources Insight》电子汇编有幸采访到在国内非常有实力的原料药生产企业--河南东泰制药有限公司与常州金晟制药厂的相关负责人，为大家介绍企业的经营理念及主打产品，小编还贴心地附上了中英文产品列表的地址哦，欢迎感兴趣的朋友阅读、收藏。
Pharma Sources Insight
August 2020
Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com andCPhI China.
August 2020 focuses on the following topics
COVID-19
Developments of COVID-19 diagnostic test
Will the Bottles be Enough with the Marketing of COVID-19 Vaccine?
Designing the Messenger: Story of the mRNA Vaccine
Inactivated Virus Vaccines vs. mRNA Vaccines: Differences between China and the U.S. in Preferred Technologies for Developing COVID-19 Vaccines
Global News
With Up to 18 First Generics, Hansoh Ranking Second in the Industry in China
A Review of the Great Journey of Capecitabine that Has Been Marketed in China for 20 Years
The Layout of Inhalation Formulations in the Chinese Market (I)
The Layout of Inhalation Formulations in the Chinese Market (II)
Brand Story
Oriented by Product Innovation, Dongtai Pharma Striving to Build a Global Characteristic Pharmaceutical Brand
"Interview Changzhou Golden Bright Pharmaceutical Factory: How to achieve safe production while ensuring quality?"
Industry Insight
Advantages to Using CROs
Scan to view the full contents
往期回顾
► 点击阅读 |
↓↓↓点击阅读原文，立即阅读《Pharma Sources Insight》